Web Analysis for Northamptonapl - northamptonapl.org
It is a domain having org extension. It has a global traffic rank of #3045680 in the world. This website is estimated worth of $ 480.00 and have a daily income of around $ 2.00. As no active threats were reported recently by users, northamptonapl.org is SAFE to browse.
PageSpeed Score
Siteadvisor Rating
Traffic Report
Daily Unique Visitors: | 276 |
Daily Pageviews: | 552 |
Estimated Valuation
Income Per Day: | $ 2.00 |
Estimated Worth: | $ 480.00 |
Search Engine Indexes
Google Indexed Pages: | 1,620 |
Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
Google Backlinks: | 12,900 |
Bing Backlinks: | Not Applicable |
Safety Information
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | No Risk Issues |
WOT Trustworthiness: | Not Applicable |
WOT Child Safety: | Not Applicable |
Website Ranks & Scores
Alexa Rank: | 3,045,680 |
Domain Authority: | Not Applicable |
Web Server Information
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
H1 Headings: | 1 | H2 Headings: | 19 |
H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | Not Applicable | Total Images: | 18 |
Google Adsense: | Not Applicable | Google Analytics: | UA-141902801-1 |
Websites Hosted on Same IP (i.e. 23.185.0.2)
Game Informer
Game Informer is your source for the latest in video game news, reviews, previews, podcasts, and features.
Home - Appcelerator | The Mobile First Platform
Home - Appcelerator -
Home | UC Santa Barbara
UC Santa Barbara is a leading center for teaching and research located on the California coast - truly a learning and living environment like no other!
The Daily Meal: #1 for Restaurants, Recipes, and Drinks
Food lovers from home cooks to professional chefs read our restaurant reviews, recipes, food news and trend reports, and entertaining and travel guides
HTTP Header Analysis
Connection: keep-alive
Cache-Control: public, max-age=0
Content-Encoding: gzip
Content-Language: en
Content-Type: text/html; charset=utf-8
Etag: W/"1577626228-0"
Expires: Sun, 19 Nov 1978 05:00:00 GMT
Last-Modified: Sun, 29 Dec 2019 13:30:28 GMT
Link: <https://northamptonapl.org/>; rel="canonical",<https://northamptonapl.org/>; rel="shortlink"
Server: nginx
X-Content-Type-Options: nosniff
X-Drupal-Cache: MISS
X-Frame-Options: SAMEORIGIN
X-Generator: Drupal 7 (http://drupal.org)
X-Pantheon-Styx-Hostname: styx-fe2-a-5bcd6cdfcc-sl7l8
X-Styx-Req-Id: 60df0ae4-2a3f-11ea-8863-9261611861f0
X-Ua-Compatible: IE=edge,chrome=1
Date: Sun, 29 Dec 2019 13:30:29 GMT
X-Served-By: cache-mdw17351-MDW, cache-pao17438-PAO
X-Cache: MISS, MISS
X-Cache-Hits: 0, 0
X-Timer: S1577626228.299500,VS0,VE1126
Vary: Accept-Encoding, Cookie, Cookie, Cookie
Age: 0
Accept-Ranges: bytes
Via: 1.1 varnish
transfer-encoding: chunked
Domain Nameserver Information
DNS Record Analysis
Host | Type | TTL | Extra |
---|---|---|---|
northamptonapl.org | A | 1395 |
IP: 23.185.0.2 |
northamptonapl.org | NS | 172800 |
Target: ns3.bdm.microsoftonline.com |
northamptonapl.org | NS | 172800 |
Target: ns4.bdm.microsoftonline.com |
northamptonapl.org | NS | 172800 |
Target: ns1.bdm.microsoftonline.com |
northamptonapl.org | NS | 172800 |
Target: ns2.bdm.microsoftonline.com |
northamptonapl.org | SOA | 300 |
MNAME: ns1.bdm.microsoftonline.com RNAME: azuredns-hostmaster.microsoft.com Serial: 1 Refresh: 3600 Retry: 300 Expire: 2419200 Minimum TTL: 300 |
northamptonapl.org | MX | 3600 |
Target: northamptonapl-org.mail.protection.outlook.com |
northamptonapl.org | TXT | 3600 |
TXT: mscid=HLIzO7gNT5VSN2NEk0ZycIP0APog6Ns7bR fnZLq9JzArg87sI9BeZelifIRGB54kwbaXqDsSPt 0GZ28+AaaXeA== |
northamptonapl.org | TXT | 3600 |
TXT: v=spf1 include:spf.protection.outlook.com -all |
Similarly Ranked Websites
Pharmaceutical Development and Commercialization 505(b)(2) | Camargo
Realize your value-added medicines faster and more cost effectively. Camargo sets the global standard for pharmaceutical development and commercialization for complex development programs for rare or orphan diseases and 505(b)(2) enhanced medications.